Loading...
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Augmentation of endogenous cannabinoid (eCB) signaling represents an emerging approach to the treatment of affective disorders. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid to form prostaglandins, but also inactivates eCBs in vitro. However, the viability of COX-2 as a therapeutic target for...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3788575/ https://ncbi.nlm.nih.gov/pubmed/23912944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3480 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|